Allegan General Hospital | |
555 Linn Street, Allegan, Michigan 49010 | |
(269) 686-4101 | |
Name | Allegan General Hospital |
---|---|
Type | Critical Access Hospital |
Location | 555 Linn Street, Allegan, Michigan |
Ownership | Voluntary non-profit - Other |
Emergency Services | Yes |
Medicare ID (CCN) | 231328 |
NPI Number | 1295803377 |
Organization Name | ASCENSION BORGESS ALLEGAN HOSPITAL |
Address | 555 Linn St, Allegan, MI 49010 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 269-686-4051 |
News Archive
InfoLogix, Inc. (Nasdaq: IFLG), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that it received a deficiency letter, dated September 16, 2009, from the NASDAQ Stock Market stating that based on the closing bid price of the company's listed securities for the last 30 consecutive business days, InfoLogix no longer meets the minimum $1.00 per share requirement for continued listing on The NASDAQ Capital Market under Marketplace Rule 5550(a)(2).
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Lexicomp has been selected by the University Health Network (UHN) as the drug information resource for its four hospitals located in Toronto, Canada.
SONOSCANNER, a French company specializing in ultrasound systems, today announced that it received the Food and Drug Administration's approval to market its new multi-purpose device, the U-lite EXP, in the United States, starting in October 2017.
Cancer development is a complex process involving both genetic and epigenetic changes. Genetic changes in oncogenes and tumor-suppressor genes are generally considered as primary causes, since these genes may directly regulate cellular growth. In addition, it has been found that changes in epigenetic factors, through mutation or altered gene expression, may contribute to cancer development.
The U.S. Food and Drug Administration today approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that causes lung infections.
› Verified 9 days ago
Able to receive lab results electronically | Not Available |
Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
InfoLogix, Inc. (Nasdaq: IFLG), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that it received a deficiency letter, dated September 16, 2009, from the NASDAQ Stock Market stating that based on the closing bid price of the company's listed securities for the last 30 consecutive business days, InfoLogix no longer meets the minimum $1.00 per share requirement for continued listing on The NASDAQ Capital Market under Marketplace Rule 5550(a)(2).
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Lexicomp has been selected by the University Health Network (UHN) as the drug information resource for its four hospitals located in Toronto, Canada.
SONOSCANNER, a French company specializing in ultrasound systems, today announced that it received the Food and Drug Administration's approval to market its new multi-purpose device, the U-lite EXP, in the United States, starting in October 2017.
Cancer development is a complex process involving both genetic and epigenetic changes. Genetic changes in oncogenes and tumor-suppressor genes are generally considered as primary causes, since these genes may directly regulate cellular growth. In addition, it has been found that changes in epigenetic factors, through mutation or altered gene expression, may contribute to cancer development.
The U.S. Food and Drug Administration today approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that causes lung infections.
› Verified 9 days ago
Allegan General Hospital Critical Access Hospital Location: 555 Linn Street, Allegan, Michigan 49010 Phone: (269) 686-4101 |